Chapter 17: Problem 3
What is the mechanism by which the chemical 5-azacytidine enhances gene expression?
/*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none}
Learning Materials
Features
Discover
Chapter 17: Problem 3
What is the mechanism by which the chemical 5-azacytidine enhances gene expression?
All the tools & learning materials you need for study success - in one app.
Get started for free
Present an overview of RNA-induced gene silencing achieved through RNA interference (RNAi). How do the silencing processes begin, and what major components participate?
A particular type of anemia in humans, called \(\beta\) -thalassemia, results from a severe reduction or absence of a normal \(\beta\) chain of hemoglobin. A variety of studies have explored the use of 5-azacytidine for the treatment of such patients. How might administration of 5-azacytidine be an effective treatment for \(\beta\) -thalassemia? Would you consider adverse side-effects likely? Why?
How does the inherent imprecision of recombination events during immunoglobulin gene rearrangement contribute to the diversity of the immune response?
Distinguish between the \(c\) is-acting regulatory elements referred to as promoters and enhancers.
Incorrectly spliced RNAs often lead to human pathologies. Scientists have examined human cancer cells for splicespecific changes and found that many of the changes disrupt tumor-suppressor gene function (Xu and Lee, 2003 . Nucl. Acids Res. \(31: 5635-5643\) ). In general, what would be the effects of splicing changes on these RNAs and the function of tumor-suppressor gene function? How might loss of splicing specificity be associated with cancer?
What do you think about this solution?
We value your feedback to improve our textbook solutions.